Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical ...

The commercial teams of pharmaceutical companies are looking for more data analytics and business insights and they’re willing to spend more money to do it. Those are some of the findings of a recent ...

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...

The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

BALLERUP, Denmark--(BUSINESS WIRE)--As part of LEO Pharma’s transformation towards becoming a global leader in medical dermatology, the company today announced a refocused commercial structure to ...

In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...

The company is developing innovative therapies for rare diseases like the exon-skipping therapy VILTEPSO®. PARAMUS, N.J., Nov. 26, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma) announced a change ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

Evoke Pharma, Inc. has appointed Greg Pyszczymuka to its Board of Directors as of February 20, 2025, marking the second addition to the board from Nantahala Capital Management, reflecting their ...

Marlborough-based pharmaceutical company Sumitomo Pharma America has selected executive Kenton Stewart as the firm’s inaugural chief commercial officer, effective Oct. 1. Having previously served as ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

Slayback Pharma LLC has appointed Sandoz and AmerisourceBergen alum Dave Picard as chief commercial officer. Picard will be based out of the firm’s Princeton office. He joins from AmerisourceBergen in ...